Archive · 24 Jul 2025
Hyderabad Researchers Develop Liver Damage Reversal Therapy
Imagine your liver is like a car engine that gets damaged.
Scientists in Hyderabad created a new way to fix these damaged engines.
They use tiny helpers called stem cells and exosomes, which are like repair kits.
This new treatment, called Tulsi-28X, was tested on animals with liver problems.
It worked really well, helping all the animals recover.
The treatment uses repair kits found in umbilical cord tissue to fix the liver.
Next, scientists will try it on humans to see if it can help people with liver damage, too.
This could be a big step forward for people who need liver help.
Hyderabad researchers developed a regenerative therapy, Tulsi-28X, to reverse liver damage.
The therapy combines stem cells and exosomes from umbilical cord tissue.
In animal trials, the treatment led to 100% survival rates compared to untreated animals.
The treatment was developed in Hyderabad over three years, involving experts from the US and Chandigarh.
Human trials are planned in partnership with NIMS, Hyderabad, and findings presented at the AASLD conference.
- Who
- Researchers at Tulsi Therapeutics, a biotech startup incubated at the University of Hyderabad's ASPIRE-BioNEST.
- What
- A regenerative therapy called Tulsi-28X that reverses liver damage.
- When
- Presented at the 2024 Liver Conference.
- Where
- Developed in Hyderabad.
- Why
- To provide a treatment where liver transplants are not an option and make affordable biologics for serious illnesses.
- Therapy Name
- Tulsi-28X
- Research Location
- Hyderabad, India
- Key Ingredients
- Stem cells and exosomes from umbilical cord tissue
- Animal Trial Survival Rate
- 100%
- Human Trial Partner
- Nizam’s Institute of Medical Sciences (NIMS)
- Conference
- AASLD